Skip to main content

Deadly meningitis outbreak tied to more drugs, FDA says

By Bloomberg  
   October 16, 2012

A second steroid manufactured by New England Compounding Center has been linked to another potential meningitis infection, U.S. regulators said. The second steroid, triamcinolone acetonide, is used to treat skin conditions that result in itching, redness, dryness, and inflammation, according to the National Institutes of Health. The patients received the medication through an epidural injection. Transplant patients have also experienced fungal infections after being given a drug from the pharmacy meant to induce cardiac muscle paralysis during open-heart surgery, the Food and Drug Administration said.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.